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ABSTRACT Three-dimensional structures were determined for three crystal forms of the antigen binding fragment (Fab) of
anti-fluorescein antibody 4-4-20 in complex with fluorescein. These included 1) a triclinic (P1) form crystallized in 47% (v/v)
2-methyl-2,4-pentanediol (MPD); 2) a triclinic (P1) form crystallized in 16% (w/v) poly(ethylene glycol), molecular weight 3350
(PEG); and 3) a monoclinic (P21) form crystallized in 16% PEG. Solvent molecules were added to the three models and the
structures were refined to their diffraction limits (1.75-A, 1.78-A, and 2.49-A resolution for the MPD, triclinic PEG, and monoclinic
PEG forms, respectively). Comparisons of these structures were interesting because 4-4-20 exhibited a lower antigen-binding
affinity in 47% MPD (Ka = 1.3 x 108 M-1) than in either 16% PEG (Ka = 2.9 x 109 M-1) or phosphate-buffered saline (Ka =
1.8 x 1010 M-1). Even though the solution behavior of the antibody was significantly different in MPD and PEG, the crystal
structures were remarkably similar. In all three structures, the fluorescein-combining site was an aromatic slot formed by
tyrosines L32, H96, and H97 and tryptophans L96 and H33. In addition, several active site constituents formed an electrostatic
network with the ligand. These included a salt link between arginine L34 and one of fluorescein's enolate oxygen atoms, a
hydrogen bond between histidine L27d and the second enolic group, a hydrogen bond between tyrosine L32 and the phe-
nylcarboxylate group, and two medium range (-5 A) electrostatic interactions with lysine L50 and arginine H52. The only major
difference between the triclinic MPD and PEG structures was the degree of hydration of the antigen-combining site. Three water
molecules participated in the above electrostatic network in the MPD structure, while eight were involved in the PEG structure.
Based on this observation, we believe that 4-4-20 exhibits a lower affinity in MPD due to the depletion of the hydration shell
of the antigen-combining site.
INTRODUCTION
Antibodies are archetypal of a number of different proteins
in the immunoglobulin supergene family, which makes them
excellent model systems for studying problems of molecular
recognition in the immune system. In particular, by studying
antigen-antibody interactions at the molecular level, we hope
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to comprehend how structural elements translate into the af-
finity and specificity of antigen-combining sites. Such
mechanistic models should facilitate the engineering of an-
tibodies and related proteins for applications in clinical di-
agnostics, medical imaging, and targeted drug delivery.
Several three-dimensional structures of antigen-antibody
complexes have been reported in the last decade. These in-
clude: 1) complexes with proteins such as lysozyme, neu-
raminadase, histidine-containing protein (HPr), and human
immunodeficiency virus type 1 (HIV-1) reverse transcriptase
(Amit et al., 1986; Colman et al., 1987; Sheriff et al., 1987;
Colman et al., 1989; Padlan et al., 1989; Davies et al., 1990;
Jacobo-Molina et al., 1993; Prasad et al., 1993); 2) com-
plexes with synthetic peptides derived from myohe-
merythrin, influenza hemagglutinin, and HIV-1 envelope
glycoprotein gpl20 (Stura et al., 1989; Stanfield et al., 1990;
Rini et al., 1992, 1993; Ghiara et al., 1994); 3) complexes
with haptens such as fluorescein, 2-phenyloxazolone, phos-
phocholine, progesterone, and cyclosporin A (Padlan et al.,
1985; Herron et al., 1989; Alzari et al., 1990; Altschuh et al.,
1992; Arevalo et al., 1993; Vix et al., 1993); and 4) a complex
with a deoxynucleotide (Herron et al., 1991). Several struc-
tures have been compared in recent review articles (Davies
et al., 1990; Mian et al., 1991; Wilson et al., 1991; Wilson
and Stanfield, 1993). There appear to be several components
to specific binding, including the topology of the antigen-
combining site, the amount of solvent-accessible surface area
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(including both antigen and antibody) that is buried upon
binding, and electrostatic interactions such as hydrogen
bonds and salt links. Moreover, recent studies in our group,
as well as in Ian Wilson's laboratory, have shown that there
is a fourth mechanism (induced fit) that in some cases enables
the antibody to change its conformation in order to achieve
greater complementarity (Herron et al., 1991; Rini et al.,
1992; Arevalo et al., 1993).
Of the above antigen-antibody complexes, the anti-
fluorescein 4-4 20 system is the best characterized in so-
lution. Physicochemical information has been obtained for
4 4 20 and related antibodies over the past decade, includ-
ing antigen-binding affinities under different conditions
(Kranz et al., 1982; Herron, 1984; Gibson et al., 1988;
Omelyanenko et al., 1993), kinetics (Kranz and Voss, 1981;
Kranz et al., 1981, 1982; Herron and Voss, 1983; Herron,
1984), thermodynamics (Herron et al., 1986; Gibson et al.,
1988), and amino acid sequences (Reinitz et al., 1988;
Bedzyk et al., 1989, 1990a, b; Dombrink-Kurtzman et al.,
1989). Furthermore, the three-dimensional structure of the
4-4-20 Fab/fluorescein complex was determined at 2.7-A
resolution by our group in 1989 (Herron et al., 1989). This
study indicated that fluorescein binds tightly in an aromatic
slot and participates in a network of electrostatic interactions.
In our original studies, crystals were grown in 47% (v/v)
MPD and crystallized in a triclinic space group (P1). Since
high concentrations of diols such as MPD and glycerol are
sometimes used to elute antibodies from affinity chroma-
tography columns, we decided to compare the affinity and
thermodynamics of the 4-4-20/fluorescein complex in
phosphate-buffered saline (PBS) and 47% MPD. We found
that the affinity was - 140-fold lower in MPD than in PBS
(Gibson et al., 1988). This posed the question of whether the
decrease in affinity was due exclusively to solvent effects or
if the fundamental structure of the antigen-combining site
had changed as well. We were able to crystallize the 4-4-20
Fab/fluorescein complex in PEG (3350 molecular weight),
which we thought would be a more "native" crystallizing
agent (Gibson et al., 1988). Two crystal forms were obtained
in PEG: 1) a triclinic (P1) form nearly isomorphous to the
MPD form and 2) a monoclinic form (P21) with one Fab
fragment per asymmetric unit. Since the original structure of
the 4-4-20 Fab/fluorescein complex was reported, the x-ray
analyses have been extended to 1.75-A resolution for the
MPD form, to 1.78-A resolution for the triclinic PEG form,
and to 2.5-A resolution for the monoclinic PEG form. The
structures of the three complexes are compared in detail in
this article.
MATERIALS AND METHODS
Crystallographic analysis
The 4-4-20 Fab-fluorescein complex was prepared and crystallized as de-
scribed by Gibson et al. (1988). Crystals were grown in either 47% (v/v)
MPD or 16% (w/v) PEG-3350. Samples crystallized with PEG early in the
project were found to have monoclinic space groups and were mostly
twinned. Later samples purified under more stringent requirements of light
exclusion and temperature control (13 ± 2°C) produced crystals with tri-
clinic space groups and crystal morphology nearly identical with MPD
forms. Diffraction data were collected with a Siemens-Nicolet P21 diffrac-
tometer equipped with a scintillation detector and helium chamber. Space
groups were initially determined using 80 or 10° precession photos, although
the lattice parameters used for structure determination were obtained
from diffractometer data. In cases where indexing was difficult, 30 preces-
sion photos were used to align the crystal and adjust the arcs of the goni-
ometer. Diffraction data were collected using an omega step scan procedure
(Wyckoff et al., 1967) and intensities were corrected for background, ab-
sorption, and radiation damage as previously described (Edmundson et al.,
1972). Four crystals were used to collect the data set for the MPD form. An
attempt was made to extend the data to d spacings of 1.5-A, but the re-
flections were mostly unobserved beyond 1.75-A. The PEG triclinic form
was particularly resistant to radiation damage, and only one crystal was
required for data collection. One crystal was sufficient for the PEG mono-
clinic form, but the data extended only to 2.5-A resolution.
Molecular replacement
Molecular replacement techniques (Rossmann and Blow, 1962; Lattman
and Love, 1970; Crowther, 1972; Cygler and Anderson, 1988a, b; Fitzger-
ald, 1988) were used to determine the orientations of the Fabs within the
unit cells of the two PEG forms. The 1.75-A structure of the MPD form was
used as a starting model. The fast rotation function (Crowther, 1972) was
used to find the rotational orientations of the VL-VH pair and the CL-CH pair,
and then those of individual domains. Next, these orientations were "fine-
tuned" using the Lattmann-Love rotation function (Lattman and Love,
1970). The translational orientations of the four domains were determined
either with the MERLOT program (Fitzgerald, 1988) or a real space trans-
lational searching program (RTMAP) written by one of us (X.M.H.). Fi-
nally, the positions of the four domains were refined by constrained-
restrained least square refinement with the program CORELS (Herzberg and
Sussman, 1983).
Crystallographic refinement and model building
Once the low resolution structures of the PEG crystal forms were deter-
mined, crystallographic refinement techniques were used to extend the
phases of all three structures to higher resolution. Structures were first re-
fined by simulated annealing with X-PLOR (Brunger et al., 1987) using the
standard topology and parameter files (TOPH19x and PARAM19x). The
slow cooling (4000 K to 300 K) protocol was used, followed by energy
minimization (with x-ray terms included). Electron density maps [F.-F,
OMIT maps (Bhat and Cohen, 1984), and 2F0-F, maps] were then examined
using the molecular graphics program Turbo FRODO (Roussel and
Cambillau, 1989). This process was repeated three to five times until each
structure stabilized. At this point, the structures were solvated as described
in Results and refined again by simulated annealing. In this case, however,
a more abbreviated temperature range was used (2000 K to 300 K, after the
initial placement of the water molecules; and 1000 K to 300 K, thereafter)
along with the force field parameters described by Engh and Huber (1991).
Restrained least-squares refinement with PROLSQ (Hendrickson and
Konnert, 1981) was used to produce the final structure. Coordinate errors
were estimated by two different methods: Luzzati's method for determining
the overall rms error of the structure from the variation in R value with
resolution (Luzzati, 1952) and Cruickshank's formulae for estimating in-
dividual coordinate errors from Fourier methods (Cruickshank, 1949, 1950,
1954; Fujinaga et al., 1985). In the latter case, estimated coordinate errors
were computed using a program (SIGMA) written by Steven Sheriff
(Bristol-Myers Squibb). This program was modified by two of us (X.M.H.
and J.N.H.) for monoclinic and triclinic space groups.
Affinity measurements using
fluorescence methodology
Fluorescence methodology and algorithms for determining the affinity of
anti-fluorescein antibodies were previously described by one of us (Herron,
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1984). Fluorescence measurements were made using a photon-counting
spectrofluorometer (model PC-1, ISS, Champaign, IL). Samples were ex-
cited with plane polarized light at 485 nm. Emission was measured at 515
nm with the emission polarizer first parallel, and then perpendicular. Emis-
sion data were corrected for polarization dependencies in the detection sys-
tem ("g-factor" correction) and then used to determine fluorescence inten-
sity and steady-state anisotropy values. Fluorescence measurements were
taken at several different concentrations of PEG-3350 over a range of 0%
to 20% (w/v) and used to compute the antigen-binding affinity (K).
RESULTS
Affinity measurements
As mentioned in the Introduction, the antigen-binding af-
finity of 4 4 20 was lower in the two solvent systems used
to crystallize the Fab fragment than in PBS. Although we had
previously characterized the affinity of 4-4-20 dissolved in
aqueous solutions ofMPD (Gibson et al., 1988), similar data
had not been obtained for 4-4-20 in PEG solutions. For this
reason, the affinity of 4-4-20 was determined in aqueous
solutions of PEG-3350, varying from 0% to 20% (w/v).
These data are presented in Fig. 1 B. Comparable data for the
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FIGURE 1 Antigen-binding affinity of 4-4-20 in MPD (A) and PEG-
3350 (B). Affinity values were determined by fluorescence quenching assay
(Herron, 1984). The 4-4-20 Fab/fluorescein complex was crystallized in
47% MPD and 16% PEG-3350.
MPD form are shown in A. Affinity values are listed in Table
1 for the solvent compositions in the crystallization media.
The affinity is 6.2-fold lower (1.1 kcal mol') in 16% PEG
and 138-fold lower (2.9 kcal mol-') in 47% MPD than in
PBS. Although neither solvent is "physiological," the affinity
of the PEG form is much closer to that in a "native" envi-
ronment than the MPD form.
X-ray diffraction data
The lattice parameters, resolution limits, and merging sta-
tistics are presented in Table 2. The lattice parameters of the
two triclinic forms differed by <1% (Table 2); when their
data sets were scaled and compared, they exhibited a "good-
ness of fit" parameter (Rf, see Table 2 for definition) of 0.190
over a resolution range of 1.78 A to mo. Together, these ob-
servations indicated that the two triclinic forms were nearly
isomorphous but probably exhibited subtle differences in
their tertiary structures. Another interesting observation was
that the a and b cell dimensions of the triclinic PEG form
were very similar in length to the a and c dimensions of the
monoclinic PEG form (Table 2). Furthermore, the (3-angle
of the monoclinic form (95.20) was supplementary to the
'y-angle of the triclinic form (84.70). These observations
suggested that the orientation of the Fab in the ab plane
of the triclinic form may be similar to that in the ac plane
of the monoclinic form. Data sets for the MPD form were
merged by scaling common shells (6.5-A to m0) for the
four crystals. The merging statistics (Rm, see Table 2 for
definition) for these crystals ranged from 7% to 9%
(Table 2).
Amino acid sequences
The amino acid sequences of the variable domains (VL and
VH) of 4 4 20 are shown in Fig. 2. They were deduced from
nucleotide sequences as described previously (Bedzyk et al.,
1989, 1990a). Two different sequence numbering systems
were used: 1) a strict sequential numbering system (used in
TABLE 1 Antigen-binding affinity of 4-4-20 In different
solvent systems
Affinity AAG0pas
Solvent (M-l) (kcal mol-')
PBS 1.8 ± 0.3 X 1010 0.0
PEG 2.9 ± 0.4 x 109 1.1
MPD 1.3 ± 0.3 x 108 2.9
Antigen-binding affinities were determined by fluorescent quenching
assay (Herron, 1984). All measurements were performed at 250C. Af-
finities were determined in three different solvent systems: 1) 50 mM
sodium phosphate, 100 mM NaCl, pH 6.8 (PBS); 2) 16% (w/v) poly-
(ethylene glycol) (3350 MW), dissolved in PBS, pH 6.8 (PEG); and 3)
47% (v/v) 2-methyl-2,4-pentanediol, dissolved in PBS, pH 6.8 (MPD).
To evaluate the destabilizing effects of the different solvent systems, the
difference in standard free energy (for the formation of the 4- -20/
fluorescein complex) was calculated relative to PBS (AAG0PBS). Posi-
tive values represent destabilizing effects.
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TABLE 2 Crystal systems and x-ray diffraction data for 4-4-20
Crystal systems*
Space a b c a l3 y Resolution Number
Protein group (A) (A) (A) (0) (0) (0) of data (A) of crystals
MPD P1 58.3 43.9 42.5 82.1 87.3 84.6 1.75 4
PEG P1 58.2 44.1 42.9 81.6 86.5 84.7 1.78 1
PEG P21 58.6 97.2 44.5 90.0 95.2 90.0 2.49 1
Diffraction datat
Crystal Resolution Number of Number Inter-crystal
no. range reflections observed Rm
MPD P1 1 2.5-oo 14,451 10,271
2 2.1-2.5 9,477 6,983 0.082
3 1.8-2.1 12,963 5,680 0.089
4 1.5-1.8 5,240 1,155 0.075
PEG P1 1 1.78-oo 39,064 27,570 0.190§
PEG P21 1 2.49-oo 18,559 14,134
*The 4-4-20 Fab/fluorescein complex was crystallized in 47% (v/v) MPD and in 16% (w/v) PEG-3350. Space groups were initially determined using 80
or 100 precession photos, although the lattice parameters used for structure determination were obtained from diffractometer data.
$Diffraction data were collected with a Siemens-Nicolet P21 diffractometer using an omega step scan procedure (Wyckoff et al., 1967) and intensities were
corrected for background, absorption, and radiation damage as described previously (Edmundson et al., 1972). Four crystals were used to collect the data
sets for the MPD form. Data sets were merged by scaling common shells (6.5-A to x0) for the four crystals. Inter-crystal R values (R.) for these mergings
are shown in the column on the right. Rm is defined as Rm = 2 F - F21 /Z Fll , where F1 and F21 are the observed structure factor amplitudes
for the 6.5-A to 00 shells of the two data sets being merged. The PEG triclinic form was particularly resistant to radiation damage, and only one crystal
was required for data collection. One crystal was sufficient for the PEG monoclinic form, but the data extended only to 2.5-A resolution.
I The R value (Rf) comparing the two triclinic data sets (PEG-Pl vs. MPD-P1) is defined as Rf = Ii Fp,dl- IF gl F Il where F,,dl and
Fpl, are the observed structure factor amplitudes of the MPD and triclinic PEG forms, respectively. It was computed over a resolution
range of 1.78 A to infinity.
our computer graphics workstations); and 2) the general im-
munoglobulin numbering scheme described by Kabat et al.
(1991). The latter was used throughout the text. It should
be mentioned that Kabat's numbering of the third com-
plementarity-determining region of the heavy chain (H3)
was different than that described by Bedzyk et al. Spe-
cifically, Bedzyk et al. used the numbers 100a-lOOd for
the sequence YYGM, while Kabat et al. used the numbers
96-99. Amino acid sequences for the constant domains
(CL and CH') were taken from Kabat et al. (1991). A
consensus sequence based on 11 murine K light chains
(Nos. 11-21) was used for the CL domain, and a consensus
sequence was taken from four murine IgG2a antibodies
(Nos. 92-95) for the CH1 domain.
Refinement of the MPD structure
The MPD structure was refined from 2.7-1.75-A by simu-
lated annealing with X-PLOR (Brunger et al., 1987) and
water molecules were added. Their positions were identified
in F0-Fc maps, which were calculated using phases from the1.75-A model. The maps were contoured at the 3 o(p) level,
where o- is the standard deviation and p is the electron den-
sity. Water molecules were only assigned to peaks that were
more than 2.5 A away from the protein. Next, the solvated
structure was refined by simulated annealing and re-
examined using both FO-F0 OMIT maps (Bhat and Cohen,
1984) and 2FO-Fc maps. OMIT maps were contoured at the
3a (p) level and 2FO-Fc maps were contoured at the 2ar (p)
level. Only water molecules that satisfied the following three
criteria were retained in the model: 1) electron density was
observed in both types of maps; 2) the nearest neighboring
atom was at least 2.5 A away; and 3) at least one hydrogen
bond (or other electrostatic interaction) was formed between
the water molecule and its neighbors. Also, maps were
searched for unassigned solvent density that had been missed
on the first pass. This cycle was repeated until the number
of solvent molecules stabilized at 297. Once the structure was
solvated, restrained least-squares refinement with PROLSQ
(Hendrickson and Konnert, 1981) was used to produce the final
structure with optimized stereochemistry. The results of the final
refinement are presented in Table 3. An F.-F, OMIT map of the
antigen-combining site is shown in the top panel of Fig. 3. In our
original 2.7-A structure of the MPD form, we had placed an
MPD molecule into unassiged electron density that was located
deep within the antigen-combining site (Herron et al., 1989).
Interestingly, after refinement at 1.75-A this electron density
seemed more appropriate for two water molecules (W27 and
W65), which were substituted for MPD.
Refinement of the PEG structures
Once the MPD structure was completed, we used it as a
starting model for molecular replacement studies with the
triclinic PEG data set. These studies confirmed our hypoth-
esis that the Fab had the same orientation within the unit cell
in both triclinic crystal forms (MPD and PEG). Following
molecular replacement, the triclinic PEG structure was re-
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FIGURE 2 (A) Amino acid sequences of the
"variable" domains of the light and heavy chains
(VL and VH) of the 4 4 20 antibody, as deduced
from nucleotide sequences by Bedzyk et al.
(1989, 1990a). (*) The strict sequential number-
ing system used in our computer graphics work-
stations. (t) A general numbering scheme intro-
duced for immunoglobulins by Kabat et al.
(1991). The latter number scheme was used
throughout the text. Framework (FR) and
complementarity-determining regions (CDR) are
denoted above the sequence numbers. Key con-
tact residues in the antigen-combining site are
highlighted. (B) Chemical structure of fluores-
cein with atom labels. This labeling scheme was
used throughout the text.
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fined to 1.78-A resolution and solvated with 287 water mol-
ecules as described above. Refinement results are presented
in Table 3, and an Fo-Fc OMIT map of the antigen-combining
site is shown in the middle panel of Fig. 3.
The 1.78-A structure of the triclinic PEG form was then
employed as the starting model for studies with the mono-
clinic PEG data set. These studies confirmed that the ori-
entation of the Fab fragment in the ac plane of the mono-
clinic structure was nearly identical to the orientation
found in the ab plane of the triclinic structure (Fig. 4).
Thus, the two PEG forms appeared to be packing variants
of each other. The monoclinic PEG model was refined to
2.49-A resolution and solvated as described above. Re-
finement results are presented in Table 3, and an Fo-Fc
OMIT map of the antigen-combining site is shown in the
bottom panel of Fig. 3. A total of 179 water molecules
were assigned, -38% fewer than observed for the tri-
clinic PEG structure.
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TABLE 3 Summary of refinement results*
4 4 20 Fab/fluorescein
Protein crystal form MPD PEG PEG
space group P1 P1 P21
Resolution limits (A) 1.75-6.0 1.78-6.0 2.49-6.0
Number of reflections 24,700 26,297 12,114
R valuet 0.207 0.214 0.184
Coordinate error (A)§
(Luzzati) 0.2M0.25 0.20-0.25 0.25
(Cruickshank) 0.24 0.25 0.30
Average temperature factor (A2) 15.5 18.5 19.5
Number of water molecules 297 287 179
Actual RMS deviation Target
rms deviations from ideal distance (A)
Bond distance 0.016 0.017 0.015 0.020
Angle distance 0.034 0.034 0.036 0.030
Planar 1-4 distance 0.039 0.038 0.039 0.040
Hydrogen bonds' 0.042 0.044 0.046 0.050
rms deviation from planarity (A) 0.020 0.020 0.020 0.025
rms deviation from ideal chirality (A3) 0.141 0.143 0.145 0.150
rms deviation from permitted contact distance (A)
Single torsion contacts 0.209 0.201 0.208 0.300
Multiple torsion contacts 0.274 0.247 0.281 0.300
Possible hydrogen bond 0.284 0.290 0.269 0.300
rms deviation from ideal torsion angles (0)
For planar group (00 or 1800) 5.5 6.8 5.2 3.0
For staggered group (±60° or 1800) 22.3 23.0 23.9 15.0
For orthonormal group (±900) 22.6 26.9 26.2 15.0
*Structures were refined by simulated annealing with X-PLOR. Final refinements were performed with PROLSQ. Weighting factors for PROLSQ were
obtained from the equation X = (1/aT)2, where of = 15.2-70.0 [sin (H)/A-1/6] for the MPD structure; or = 11.6-69.0[sin (O)/A-1/6] for the triclinic PEG structure;
and a = 17.5-129.5[sin (O)/A-1/6] for the monoclinic PEG structure.
tAt 2.0 A resolution with comparable refinement statistics, the MPD (Pl) form exhibited an R value of 0.196 for 19,808 reflections, and the PEG (P1) form
exhibited an R value of 0.202 for 21,615 reflections.
§Coordinate errors were estimated by two different methods: Luzzati's method for determining the overall rms error of the structure from the variation in
R value with resolution (Luzzati, 1952) and Cruickshank's formulae for estimating individual coordinate errors from Fourier methods (Cruickshank, 1949,
1950, 1954; Fujinaga et al., 1985). In the latter case, the error for the overall structure was determined by taking the rms average of the individual coordinate
errors.
'Explicit hydrogen bonds for ,B-pleated sheets.
Comparison of the MPD and PEG triclinic forms
Fig. 5 (top) shows a comparison of the C. skeletal models
of the two triclinic structures. They were very similar, even
though their antigen-binding affinities differed by more than
20-fold (AAGO= 1.8 kcal mol', Table 1). For example, the
two Fab fragments had nearly the same elbow-bend angles
(173.40 and 174.20 for the MPD and PEG forms, respec-
tively). In addition, the rms difference between the two struc-
tures for all C. atoms was 0.71 A. In another analysis, the
C. traces of the variable domain dimers (VL-VH) of the two
triclinic structures were superimposed and key contact resi-
dues in the antigen-combining site were compared (Fig. 6,
top). The rms differences between contact residues (all atoms
in each contact residue were included in the analysis) varied
between 0.28 A and 0.65 A for the individual residues, with
a combined average of 0.42 A (Table 4). To assess whether
any of these differences were significant, the rms errors in
the positions of the contact residues were estimated by
the Cruickshank method (Cruickshank, 1949, 1950, 1954;
Fujinaga et al., 1985). The results of this error analysis are
presented in Table 4 and indicated that only three of the
above rms differences (Ser-L91, Ser-H95, Gly-H98) were
significant at the 95% confidence level, and only one (Ser-
H95) was significant at the 99% level. Although the side
chain of Ser-L91 forms a hydrogen bond with fluorescein,
the other two residues only make minor contributions to
binding (Table 8). Thus, the changes in the positions of these
residues are probably not responsible for the observed dif-
ference in affinity. This issue will be discussed more thor-
oughly in a later section.
Although the two triclinic structures were similar, several
regions of polypeptide backbone exhibited rms differences
>1 A (Table 5). These regions comprised only about 6% of
the total protein structure, but were interesting to examine
because they probably represented segments of above aver-
age mobility. There was substantial supporting evidence for
this suggestion. First, the observed differences were not due
to packing interactions because the two triclinic forms were
nearly isomorphous. Second, all of the regions were located
near the surface of the molecule and were constrained by
little, if any, secondary structure. Third, the temperature fac-
tors for these regions were 25-50% above average, as is often
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FIGURE 3 Stereo diagram of
F.-F, OMIT maps for the antigen-
combining site of the 4-4-20 Fab/
fluorescein complex. All atoms in
fluorescein and the following contact
residues were deleted from structure
factor calculations (Fe): His-L27d,
Tyr-L32, Trp-L96, Trp-H33, Tyr-
H97, Tyr-H96. Maps were contoured
at a level of 2.5a (p), where o is the
standard deviation and p is electron
density. (Top) 1.75-A structure ofthe
MPD form. Fluorescein is in the cen-
ter of the photo, with residues His-
L27d, Tyr-L32, Tyr-H97, Tyr-H96,
Trp-L96, and Trp-H33 (clockwise
from bottom left). (Middle) 1.78-A
structure of the triclinic PEG form.
Pictured residues are the same. (Bot-
tom) 2.49-A structure of the mono-
clinic MPD form.
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FIGURE 4 Stereo packing diagram comparing the ab plane of the triclinic PEG form (blue) to the ac plane of the monoclinic PEG form (red).
FIGURE 5 Stereo diagrams comparing the C. traces of dif-
ferent crystal forms of the 4-4-20 Fab/fluorescein complex.
(Top) comparison of the two triclinic forms. MPD is shown
in yellow and PEG is shown in blue. Regions where the two
forms overlap exhibit a "calico" appearance. (Bottom) com-
parison of the two PEG forms. Triclinic is shown in blue and
monoclinic is shown in red.
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FIGURE 6 Stereo diagrams comparing the tertiary
structure of key active site residues in the three crystal
forms. (Top) comparison of the two triclinic forms.
MPD is shown in yellow and PEG is shown in blue.
Fluorescein is in the center of the photo, with residues
His-L27d, Tyr-L32, Tyr-H97, Tyr-H96, Trp-L96, and
Trp-H33 (clockwise from bottom, left). Arg-L34 is lo-
cated to the rear of fluorescein. (Bottom) comparison of
the two PEG forms. Triclinic is shown in blue and mono-
clinic is shown in red. Pictured residues are the same.
observed with mobile surface residues, and the electron den-
sity was well defined for these segments. Finally, homolo-
gous regions also exhibited above-average mobility in the
BV04-01 Fab fragment, which crystallized in a triclinic
space group with lattice parameters and Fab orientations
similar to those in the MPD form of 4-4-20 (Herron et al.,
1991).
Water molecules assigned to the two triclinic structures
were similar in number (297 in the MPD form vs. 287 in the
PEG form) but differed somewhat in distribution pattern.
This distribution was evaluated in two ways. First, the num-
ber of hydrogen bonds formed between water molecules and
protein constituents was calculated, as well as the number
formed between pairs of water molecules. Second, water
molecules were classified into two categories: those which
were hydrogen bonded to protein constituents, and those
which were only hydrogen bonded to other water molecules.
In essence, water molecules in the former category belonged
to the inner hydration shell of the Fab, while those in the latter
category did not associate directly with the protein.
The results of these analyses are presented in Table 6 and
suggested that the PEG form exhibited a more organized
inner hydration shell. For example, it exhibited both a greater
number of protein-water hydrogen bonds (287 for PEG vs.
253 for MPD) and a slightly higher number of water mol-
ecules which were hydrogen bonded to protein constituents
(181 for PEG vs. 175 for MPD). In contrast, the MPD form
exhibited higher numbers of both water-water hydrogen
bonds (156 for MPD vs. 149 for PEG) and water molecules
which were only hydrogen bonded to other water molecules
(122 for MPD vs. 106 for PEG). These observations may be
due to the different concentrations of precipitants used to
grow the two crystal forms; 47% (v/v) MPD is probably more
hygroscopic than 16% (w/v) PEG and hence may cause
greater disruption of the inner hydration shell of the MPD
form. This issue will be examined further in the Discussion.
Comparison of the triclinic and monoclinic
PEG forms
The two PEG forms were compared by the methods used to
analyze the two triclinic forms. Skeletal Ca models are shown
in the bottom panel of Fig. 5, and key contact residues in the
antigen-combining site are presented in the bottom panel of
Fig. 6. The elbow-bend angle of the monoclinic form (176.
0°) is slightly greater than that of the triclinic form (174.20),
but there are no other significant differences in quaternary
structure. The rms difference between the two PEG struc-
tures was 0.78 A for all C. atoms, compared with the value
of 0.71 A for the MPD and PEG triclinic structures. Regions
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TABLE 4 Differences In the atomic positions of contact
residues In the active sites in the three forms of the 4-4-20
Fab/fluorescein complex
MPD vs. PEG-Pl PEG-Pl vs. PEG-P21
rms rms rms rms
difference* error* difference* error*
Residue (A) (A) (A) (A)
CDR-L1
His-L27d 0.30 0.36 0.75 0.39
Gly-L29 0.56 0.43 0.15 0.40
Tyr-L32 0.36 0.25 0.58 0.31
Arg-L34 0.45 0.26 0.81' 0.29
CDR-L2
Lys-L50 0.40 0.22 0.67§ 0.33
CDR-L3
Ser-L91 0.60§ 0.30 0.55 0.32
Trp-L96 0.28 0.29 0.94' 0.33
CDR-H1
Trp-H33 0.39 0.32 0.73 0.38
CDR-H2
Arg-H52 0.38 0.31 0.61 0.33
Tyr-H53 0.31 0.39 0.86§ 0.38
CDR-H3
Ser-H95 0.65§ 0.25 0.93§ 0.34
Tyr-H96 0.47 0.34 0.69 0.40
Tyr-H97 0.48 0.32 0.55 0.40
Gly-H98 0.53§ 0.25 0.54 0.33
All contact
residues 0.42 0.31 0.72§ 0.35
*The C. traces of the variable domain dimers (VL-VH) of the two triclinic
structures (MPD vs. PEG-Pl) were superimposed and key contact residues
in the antigen-combining site were compared. Specifically, the root mean
square (rms) difference between each contact residue was computed using
the following formula:
rms difference = (i (x,,-x)2 )1/2
n
where x1, represents the atomic coordinates for an atom in the MPD structure,
x2j represents the coordinates for the same atom in the PEG-PI structure, and
n is the total number of atoms in each contact residue. This procedure was
repeated with the two PEG structures (PEG-Pt vs. PEG-P20).
*To assess whether the above rms differences were significant or not, the
rms errors in the positions of the contact residues were also determined.
Estimated coordinate errors were calculated for all atoms in the contact
residues using the Cruickshank formulae (Cruickshank, 1949, 1950, 1954;
Fujinaga et al., 1985). Because two structures were being compared (MPD
vs. PEG-PI) the combined rms error of each contact residue was computed
as follows:
En (Cr2i + 0,22) l
rms error = ( )
where ori is the estimated coordinate error for an atom in the MPD structure,
°'2i is the estimated error for the same atom in the PEG-Pt structure, and
n is the total number of atoms in each contact residue. This procedure was
repeated with the two PEG structures (PEG-Pt vs. PEG-P21).
The observed rms difference for this residue is significant at the 95% con-
fidence level (rms difference .1.96*rms error). This suggests that it oc-
cupies different positions in the two crystal forms.
of the two PEG structures differing by >1 A (rms) are listed in
Table 7. These differences were due either to dissimilar packing
interactions or to the inherent flexibilities discussed above.
Differences between key contact residues in the antigen-
two triclinic structures. The rms differences of individual
residues varied between 0.15 and 0.94 A, with a combined
average of 0.72 A (Table 4). As described above, these dif-
ferences were compared with the estimated rms coordinate
errors of the contact residues. This analysis indicated that
five of the rms differences (Arg-L34, Lys-L50, Trp-L96,
Tyr-H53, Ser-H95) were significant at the 95% confidence
level and three (Arg-L34, Trp-L96, Ser-H95) were signifi-
cant at the 99% level. Considering that both Arg-L34 and
Trp-L96 make important contributions to the electrostatic
character and shape of the antigen-combining site, it is not
surprising that fluorescein occupies slightly different posi-
tions in the two PEG structures (Fig. 6, bottom). These dif-
ferences are probably due to the dissimilar packing interac-
tions and/or different resolution levels of the two structures.
Other prominent differences involved the solvent struc-
tures. Fewer water molecules were assigned to the mono-
clinic form than to the triclinic form (179 vs. 287). In ad-
dition, the monoclinic form had fewer water molecules
hydrogen bonded to protein constituents than the triclinic
form (99 in the monoclinic vs. 181 in the triclinic; Table 6),
and fewer than half as many solvent-protein hydrogen bonds
(131 for monoclinic vs. 287 for triclinic). The monoclinic
structure also exhibited fewer water-water hydrogen bonds
than the triclinic structure (61 vs. 149). These comparisons
are of limited value, however, in trying to evaluate the water
structure of the two crystal forms because of the lower reso-
lution of the monoclinic form.
Fluorescein binding site
Practically all features previously described for the fluores-
cein binding site (Herron et al., 1989) were found in the three
present structures. To ascertain whether any other novel fea-
tures could be identified in the binding site at higher reso-
lution, we calculated the potential energies of fluorescein
with neighboring residues (Table 8). This analysis showed
that several residues located in the second and third CDRs
of the heavy chain and the second CDR of the light chain had
a greater role in binding fluorescein than we had supposed.
A new van der Waals interaction was observed between the
phenolic group of Tyr-H53 (located in H2) and fluorescein's
xanthenone ring (Table 8). Specifically, atoms CE2 and OH
of Tyr-H53 made contact with atoms C12 and C13 of fluo-
rescein. Since Tyr-H53 was located near the entrance to the
slot (in front of Trp-H33, and to the right of His-L27d), it
helped to shield the xanthenone ring from solvent. Direct
evidence for this effect was found in the two PEG structures;
a water molecule (W192) was located within hydrogen bonding
distance of Tyr-H53's hydroxyl group in the triclinic form and
two such water molecules (W126 and W127) were observed in
the monoclinic form. A new electrostatic interaction was ob-
served between the guanido group ofArg-H52 and fluorescein's
01 enolic group. Arg-H52 was located on the right side of the
site, immediately below Tyr-H53. Located 5 A away from fluo-
rescein, Arg-H52 was not a contact residue, but did contribute
combining site were somewhat larger than observed for the
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TABLE 5 Differences in tertiary structure between the MPD and PEG triclinic forms
C. displacement (A)
Region rms Maximum Comments
Light
L1-L2* 0.99 1.16 N-terminus of the light chain. The first two residues have slightly different (I and T angles in the two
[L1-L2]t crystal forms.
(DV)§
L152-L158 2.01 2.85 Extended region of polypeptide which runs perpendicular to the long axis of the CL domain. It is located on
[L157-L163] the external face of the domain, near the carboxyl end. The tertiary structure of the SERQN sequence is
(GSERQNG) essentially the same in the two crystal forms, but the two glycines allowed the MPD form to shift about
2.2 A relative to the PEG form.
Heavy
H1-H4 2.27 3.52 N-terminal segment of the heavy chain. The first two residues occupy different positions in the two crystal
(EVKL) forms due to rotations about the T angles of H2 and H3 and the (F angle of H4.
H62-H65 1.20 1.42 Extended, flexible region which connects CDR-H2 to a strand of 3-pleated sheet.
[H65-H68]
(SVKG)
H128-H134 1.40 2.51 Extended loop which forms the heavy chain half of the interchain disulfide.
[H133-H139]
(CGDTTGS)
*Immunoglobulin numbering scheme of Kabat et al. (1991).
tStrict sequential number system used in our computer graphics workstations.
§Amino acid sequence.
site. We speculate that it could also be important in directing the
fluorescein into the active site.
Several new van der Waals interactions were observed
between fluorescein's phenylcarboxylate group and the
phenolic groups of both Tyr-H96 and Tyr-H97 (located
in H3). Specifically, atoms CD1 and CE1 of Tyr-H96
made contact with atom C17 of fluorescein's phenyl ring.
Atoms CD1 and CE1 of Tyr-H97 made contact with fluo-
rescein's phenyl ring (C18 and Cl9) and its phenylcar-
boxylate group (C20, 04, 05). Potential energy calcula-
tions suggested a dipole-induced dipole interaction
between the peptide amino group (NH) of Tyr-H97 and
fluorescein's phenyl ring. Finally, the polypeptide back-
bone of the residues which flank tyrosines H96 and H97
(Ser-H95 and Gly-H98) also made van der Waals contacts
with fluorescein. In our original structure, the side chains
of Tyr-H96 and Tyr-H97 pointed toward fluorescein's
phenylcarboxylate group, but did not make contact with
it. Together, these binding site components shield fluo-
rescein from bulk solvent more effectively than previ-
ously believed.
The 2.7-A study (Herron et al., 1989) indicated that
only one of fluorescein's two negative charges was for-
mally neutralized on complexation (salt link between
Arg-L34 and fluorescein's 03 enolic group). The second
negative charge on fluorescein's phenylcarboxylate
group was partially neutralized by a hydrogen bond with
Tyr-L32. Lysine-L50 (located in L2) was apparently too
far away (5.5 A) for a strong electrostatic interaction with
the phenylcarboxylate. However, our potential energy
calculations showed that there was a favorable electro-
static interaction between Lys-L50 and fluorescein (-2.9
to -4.6 kcal/mol; Table 8). Like Arg-H52, Lys-L50 was
TABLE 6 Hydrogen bonds with solvent molecules
Number of hydrogen bonds*
Type of
hydrogen bond MPD-P1 PEG-Pl PEG-P21
Main chain
N-H-Water 39 48 13
C=O-Water 74 86 40
Side chain
Arg-Water 19 12 7
His-Water 5 5 4
Lys-Water 20 24 8
Asp-Water 14 16 12
Glu-Water 9 12 11
Asn-Water 12 15 3
Gln-Water 9 8 8
Ser-Water 29 35 13
Thr-Water 17 19 7
Trp-Water 3 1 1
Tyr-Water 3 6 4
Total protein-water 253 287 131
hydrogen bonds:
Total water-water 156 149 61
hydrogen bonds:
Location of water moleculest
Number of water molecules 175 181 99
hydrogen bonded to protein
Number of water molecules 122 106 80
only hydrogen bonded to
other waters
*The number of hydrogen bonds between water molecules and protein con-
stituents was tallied for each of the three crystal forms (MPD-P1, PEG-Pt,
PEG-P21). Data were tabulated for hydrogen bonds between solvent mol-
ecules and main chain amide and carbonyl groups, as well as for those
between solvent molecules and the side chains of polar residues.
tThe number of water molecules that form hydrogen bonds with protein con-
stituents was listed for each of the crystal forms, and the number of waters that
were only hydrogen bonded to other water molecules was also determined.
Herron et al. 2177
Volume 67 December 1994
TABLE 7 Differences in tertiary structure between the monoclinic and triclinic PEG forms
Ca displacement (A)
Region rms Maximum Comments
Light
L14-L17* 0.94 1.05 Packing interactions with H52b and H55 in triclinic form and with H65-H66 and H82b in the monoclinic
[L14-L17]t form.
(SLGD)§
L152-L157 1.55 2.36 Packing interactions with H8-H11 and H151 in the triclinic form, and with H6-H7 and H106-H107 in the
[L157-L162] monoclinic form.
(GSERQN)
L213-L214 1.43 1.56 Light chain half of the interchain disulfide bond. Packing interactions with L52 and L54 in both crystal
[L218-L219] forms.
(EC)
Heavy
H1-H3 1.04 1.29 N-terminus of heavy chain. Slightly different (D and T angles in the first three residues of the two crystal
(EVK) forms.
H25-H27 1.10 1.30 Flexible region adjacent to H1-H3; these two regions move in concert.
(SGF)
H41-H44 1.45 1.70 Packing interaction (salt link) between Glu H42 and LysH 75 in both crystal forms.
(PEKG)
H64-H65 1.27 1.41 Packing interactions with L14-L15, L106-L107 and L168-L171 in the monoclinic form and with L200-L201
[H67-H68] in triclinic form.
KG
H113-H115 1.15 1.21 Switch region peptide between the VL and CHi domains. Difference is probably due to small changes in the
[H118-H120] elbow bend angles (-2°) and pseudo-twofold angles (2-3°).
(SAK)
H130-H137 1.47 1.94 Extended loop near the heavy chain half of the interchain disulfide. Packing interactions with H15-H16 in
[H135-H140] triclinic form and with H52c-H53 in monoclinic form.
(D1TGSS)
H178-H180 1.09 1.19 Reverse turn adjacent to H113-H115; the two regions move in concert.
[H175-H177]
(LQS)
H193-H200 2.02 2.99 Packing interactions with L27e-L28 in monoclinic form. Also, this region is adjacent to H130-H137 and
[H188-H194] moves in concert.
(VTSSTWP)
*Inmunoglobulin numbering scheme of Kabat et al. (1991).
tStrict sequential number system used in our computer graphics workstations.
lAmino acid sequence.
not a contact residue, but contributed to the electroposi-
tive nature of the site, helping to mask the negative charge
on the phenylcarboxylate group.
Phenylcarboxylate also participated in several inter-
esting solvent interactions. In both triclinic structures, a
bound water molecule (W22 in the MPD form, W49 in the
PEG form) bridged the distance between NZ of Lys-L50
and 05 of the phenylcarboxylate group, and either one or
two water molecules (W23 in the MPD form, W159 and
W192 in the PEG form) were hydrogen bonded to atom
04 of the phenylcarboxylate group. Although these sol-
vent interactions were not observed in the monoclinic
PEG form, two water molecules (W126 and W127) lo-
cated in the vicinity of the phenylcarboxylate group were
observed to hydrogen bond to the OH group of Tyr-H53
instead. In summary, the negative charge on the phenyl-
carboxylate group was partially neutralized by three types
of interactions: 1) the hydrogen bond with Tyr-L32; 2) an
electrostatic interaction with Lys-L50; and 3) electro-
static interactions with solvent molecules.
DISCUSSION
Lower affinity of the MPD form
At first we thought that the lower affinity of 4-4-20 for
fluorescein in MPD would be reflected in the structure of the
active site (Gibson et al., 1988). However, since the struc-
tures of the sites in the triclinic MPD and PEG forms were
nearly identical (Tables 4 and 8, Fig. 6), other factors had to
be involved. We suggest that the observed difference in af-
finity is mainly due to the depletion of the hydration shell of
the antigen-combining site. In support of this hypothesis, the
MPD structure was found to contain fewer ordered solvent
molecules in the antigen-combining site than observed in the
triclinic PEG structure. Table 9 shows that the MPD form
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TABLE 8 Potential energy of non-bonded interactions between fluorescein and contact residues of 4-4-20
Potential energy* (kcal mol-1)
MPD-P1 PEG-Pl PEG-P21
Contact residue VDW Elec Total VDW Elec Total VDW Elec Total
CDR-L1
His-L27d 1.2 -33.8 -32.7 0.6 -33.4 -32.8 -2.3 -27.2 -29.5
Gly-L29 -0.3 -1.0 -1.3 -0.4 -1.6 -2.0 -0.4 -0.6 -1.0
Tyr-L32 -8.7 -12.7 -21.3 -6.4 -10.3 -16.7 -8.6 -11.2 -19.8
Arg-L34 -1.4 -41.0 -42.4 -1.0 -40.3 -41.3 0.2 -36.7 -36.5
CDR-L2
Lys-L50 -0.1 -4.6 -4.7 -0.1 -2.9 -3.0 -0.1 -4.1 -4.2
CDR-L3
Ser-L91 1.2 -11.0 -9.8 0.2 -3.7 -3.5 -1.5 5.2 3.7
Trp-L96 -3.0 0.0 -3.0 -2.9 -0.1 -3.0 -1.2 0.0 -1.2
CDR-H1
Trp-H33 -7.9 -0.4 -8.3 -9.7 -1.1 -10.8 -10.2 -1.1 -11.4
CDR-H2
Arg-H52 -0.3 -2.6 -2.9 -0.3 -2.4 -2.7 -0.3 -1.9 -2.2
Tyr-H53 -1.8 -1.5 -3.3 -2.5 -0.4 -2.8 -1.5 2.8 1.3
CDR-H3
Ser-H95 -1.9 -0.5 -2.3 -1.9 -1.3 -3.2 -1.3 -2.3 -3.5
Tyr-H96 -1.9 -3.6 -5.5 -4.2 -2.2 -6.4 -3.7 -3.5 -7.2
Tyr-H97 -2.0 -15.2 -17.2 -7.5 -13.4 -20.9 -3.0 -14.5 -17.5
Gly-H98 -2.8 -0.7 -3.5 -1.4 -2.6 -4.1 -2.2 -5.7 -7.8
Total for all -29.8 -128.5 -158.4 -37.5 -115.7 -153.2 -36.1 -100.7 -136.8
contact residues
*Potential energies of non-bonded interactions between fluorescein and neighboring residues in the antigen-combining site were calculated using X-PLOR
(Briinger et al., 1987). Values were reported for van der Waals (VDW) and electrostatic (Elec) interactions. The sum of these two energies (total) was also
reported for each contact residue.
TABLE 9 Potential energy of non-bonded interactions between fluorescein and solvent
Potential energy* (kcal mol 1)
MPD-P1 PEG-Pl PEG-P2
Water Water Water
no. VDW Elec Total no. VDW Elec Total no. VDW Elec Total
22 0.2 -16.1 -15.9 30 -1.1 -8.9 -9.9 42 -0.3 -2.4 -2.7
23 -0.1 -15.0 -15.1 49 -0.1 -16.9 -17.0 126 -0.1 -0.9 -0.9
214 -0.3 -5.9 -6.2 79 -0.3 -4.1 -4.4 127 -1.4 -11.9 -13.2
159 -0.2 -15.7 -15.9
192 -1.6 -13.0 -14.6
208 0.0 -0.7 -0.8
209 -0.2 -2.0 -2.3
210 -0.2 -3.0 -3.2
-0.2 -37.0 -37.2 -3.6 -64.3 -68.0 -1.7 -15.1 -16.9
*Potential energies of non-bonded interactions between fluorescein and solvent molecules in the vicinity of the antigen-combining site were calculated using
X-PLOR (Brunger et al., 1987). Values were reported for van der Waals (VDW) and electrostatic (Elec) interactions. The sum of these two energies (total)
was also reported for each solvent molecule.
contains only three water molecules which exhibited a fa-
vorable non-bonded potential energy with the fluorescein-
combining site complex (total potential energy of -37.2 kcal
mol1). In contrast eight such water molecules were
identified in the triclinic PEG structure (-68.0 kcal mol-1)
(see Fig. 7 for illustrations of the solvated antigen-combining
sites of both triclinic structures). Although potential energies
reflect the internal energy of the antigen-antibody interaction
rather than the free energy, they are still useful in assessing
the relative contributions of different structural elements to
the overall interaction. Considering that the total potential
energy of non-bonded interactions between fluorescein and
protein was -156 ± 4 kcal mol' for the two triclinic
structures, the additional solvent contribution of -30.8 kcal
mol-1 in the PEG form suggested that this structure should
have a higher affinity. Finally, the observation that the af-
Herron et al. 2179
Volume 67 December 1994
FIGURE 7 Solvation of the antigen-combining sites of the three crystal forms. Solvent-accessible surfaces were calculated as described by Connolly (1983).
Light chain residues were colored blue and heavy chain residues magenta. The solvent molecules listed in Table 9 were shown as solid red spheres. Fluorescein
is depicted as a green CPK model. (Top left) triclinic MPD form; (top right) triclinic PEG form; (bottom) monoclinic PEG form.
finity of 4 4 20 decreased monotonically with increasing
MPD or PEG concentration (Fig. 1) strongly suggested that
affinity was inversely related to the hydration properties of
the precipitant. With increasing concentration, the hygro-
scopic molecules of MPD or PEG progressively pull water
away from the protein and into their own hydration shells.
This phenomenon leads to precipitation (and crystallization)
of the Fab fragment but also lowers its affinity, apparently
without major changes in the protein structure.
Buried surface area
Several studies have shown that buried surface area is cor-
related to the hydrophobic effect, especially for buried non-
polar surfaces (Chothia, 1974; Eisenberg et al., 1984; Guy,
1985; Rose et al., 1985; Kellis et al., 1989; Spolar et al., 1989;
Makhatadze and Privalov, 1990; Privalov and Makhatadze,
1990; Sharp et al., 1991). Furthermore, there is a conversion
factor that relates nonpolar surface area to the component of
the free energy change attributable to the hydrophobic effect.
Typically, such values range from -16 to -31 cal mol-1
A 2, with an average of about -25 cal mol' A-2 (Sharp
et al., 1991). Davies et al. (1990) reported that buried surface
area ranged from 300 to 1700 A2 in a series of antigen-
antibody complexes including our 4-4-20 Fab/fluorescein
complex at 2.7-A resolution. We extended such computa-
tions to the three new structures and modified the approach
to include the fraction of buried surface area involving non-
polar constituents. These values are listed in Table 10. The
average total buried surface area in the three forms was 585
+ 8 A2, of which 338 ± 12 A2 (58%) was due to nonpolar
atoms. The free energy change due to the hydrophobic effect
was calculated to be -8.5 ± 0.3 kcal mol1 (Table 10). As
measured by fluorescence quenching assay (Herron, 1984),
the empirical AG' value for the 4-4-20/fluorescein complex
was -13.9 kcal mol at 25°C (Herron et al., 1986; Gibson
et al., 1988).
We interpret these results to imply that the aromatic bind-
ing cavity possesses a fundamental free energy of interaction
of about -8 to -9 kcal mol 1 due to the hydrophobic effect.
For promotion of complexation, the hydrophobic effect is
augmented by non-bonded interactions through van der
Waals contacts, hydrogen bonds, and salt links between fluo-
rescein and residues in the binding cavity. Moreover, elec-
trostatic interactions (hydrogen bonds, salt links) that form
between fluorescein and buried polar groups may be sig-
nificantly stronger than comparable interactions in bulk sol-
vent because of the low dielectric constant within the binding
cavity. If the correlation between buried nonpolar surface
area and hydrophobic free energy is valid, then non-bonded
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TABLE 10 Buried surface area of the 4-4-20 Fabtfluorescein
complex and calculated hydrophobic components of heat
capacity and free energy
Buried surface area (A2)*
Structural MPD- PEG- PEG-
moiety Polarity P1 P1 P21 Average
Binding site Polar+nonpolar 315 309 314 313±3
Binding site Nonpolar 162 145 148 152±9
Fluorescein Polar+nonpolar 279 271 266 272±7
Fluorescein Nonpolar 190 187 183 187±4
Complex Polar+nonpolar 594 580 580 585±8
Complex Nonpolar 352 332 331 338± 12
Calculated hydrophobic components*
AGOghydro) (kcal mol ) -8.8 -8.3 -8.3 -8.5±0.3
ACP (hydro) (cal mol-'1K-1) -99 -93 -93 -93±3
*Buried surface area was computed for the three crystal forms of the 4 4 20
Fab/fluorescein complex as described previously (Davies et al., 1990). Val-
ues were reported for: 1) the antigen-combining site without fluorescein
(binding site); 2) free fluorescein (fluorescein); and 3) the Fab/fluorescein
complex (complex). In addition, values were determined for total buried
surface area (polar + nonpolar) and nonpolar buried surface area (nonpolar).
The average buried surface area for the three crystal forms was reported in
the rightmost column.
iThe contributions of the hydrophobic effect to the free energy of binding
[AG0(hydro)] and the change in heat capacity [ACp0(hyd,o)] were calculated as
described previously (Sharp et al., 1991). A conversion factor of -25 cal
mol-1 A-2 was used to relate nonpolar, buried surface area to the free energy
of binding, while that of -0.28 cal mol-1 OK-' -2 was used to compute
the heat capacity change.
interactions are probably responsible for - -5 kcal mol 1 of
the binding energy. The 3-D structures indicate the formation
of the three hydrogen bonds and one salt link during com-
plexation. One of these hydrogen bonds and the salt link
could together account for about -4.5 kcal mol-1 of the
binding energy (Omelyanenko et al., 1993). Thus, electro-
static interactions probably play important roles in the com-
plexation of 4 4 20, as well as in the formation of other
antigen-antibody complexes of high affinity.
Induced-fit in 4-4-20
The above interpretations were made without considering
possible changes in the conformational entropy or vibrational
modes of the antigen and antibody. Immunologists have long
been interested in whether antigens and antibodies form com-
plexes between two static partners ("lock and key" mecha-
nism) or whether they can change their conformations to
achieve greater complementarity ("induced-fit" hypothesis)
(Berzofsky, 1985). In lock and key mechanisms, the change
in conformational entropy of the antibody should be minimal
because the structure of the antigen-combining site does not
change upon binding. Formation of the complex by an
induced-fit mechanism, however, "locks" both partners into
a single conformational state. Both conformational and vi-
brational entropy may therefore be significantly lower for the
antigen-antibody complex than for the unbound state. An
induced-fit mechanism should lead to an increase in the di-
versity of antigens to which a particular antibody can re-
spond. However, it is an energetically unfavorable process
and probably takes place at the expense of other more fa-
vorable interactions.
Although the native (unliganded) form of the 4-4-20
Fab has not been crystallized, several lines of evidence
suggest that an induced-fit mechanism may be involved
in the binding of fluorescein. First, kinetic studies indi-
cated a two-step association reaction-a second-order
collision event followed by a first-order accommodation
step (Kranz et al., 1982; Herron, 1984). Second, ther-
modynamic studies suggested that the binding of fluo-
rescein may be accompanied by a loss in vibrational en-
tropy (Herron et al., 1986). This conclusion was based on
the work of Sturtevant (1977), who reported that the
entropy change in many protein-ligand interactions at
25°C was much lower than predictions based on the hy-
drophobic effect. He suggested that the discrepancy may
be due to a loss in the vibrational entropy of the protein
upon binding.
Third, time-resolved fluorescence anisotropy studies in-
dicated that the hydrodynamic behavior of the 4 4 20 Fab
changed upon formation of the Fab/fluorescein complex
(Lim et al., submitted for publication). Specifically, the li-
ganded Fab was shown to have a smaller hydrodynamic vol-
ume and less segmental flexibility (i.e., to be more rigid) than
the unliganded form. These observations were consistent
with the results of molecular dynamics (MD) simulations of
the 4-4-20 Fab, performed in the presence and absence of
fluorescein, which had been undertaken to study the struc-
tural aspects of the induced-fit mechanism in 4 4 20 (Lim
and Herron, submitted for publication). These simulations
also suggested that the antigen-combining site collapsed dur-
ing the first 4 ps of the simulation, after fluorescein was
removed from the site using a simulated pulling force. After
the initial collapse, the site gradually reformed during the
next 100 ps of the simulation. Motions of the two tryptophan
residues (L96 and H33) were primarily responsible for the
collapse, although the side chain ofTyr-H53 also moved. The
movement of Trp-L96 was transmitted to the rest of the
(-strand to which it was attached (L96-L104). Although
these results are merely predictions based on MD simula-
tions, they do suggest that dissociation of fluorescein from
the antigen-combining site is accompanied by movements
in both the side chains and main chains of certain contact
residues.
Finally, the failure of the unliganded Fab to crystallize
under the same conditions as the liganded Fab suggested that
the unliganded and liganded forms may have a significantly
different conformations. This premise is supported by the
observation that polyclonal antibodies elicited against the
4 4 20/fluorescein complex were found to bind exclusively
to the liganded forms of the 4 4 20 IgG, its Fab fragment
and a recombinant single chain antibody derivative, but ex-
hibited little if any activity for the unliganded forms of these
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species (Weidner and Voss, 1991). This phenomenon has
been termed "metatypy" and may be generally operable in
immune recognition (Voss, 1990). In our combined labora-
tories the most familiar precedents for these suggestions are
the antigen-induced changes in the BV04-01 Fab (Herron
et al., 1991).
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